Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell tags : Iot save search
Sana Biotechnology to Present Preclinical Data on its Engineered Hypoimmune Allogeneic CAR T Cells at the 2022 American Association for Cancer Research Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
SANA | $8.58 6.06% 5.71% 1.2M
|
|
| O: 3.73%
H: 6.92%
C: 5.94%
america technology research cel preclinical cancer biotech iot t-cell pre-clinical
Adaptive Biotechnologies Announces New Data Demonstrating ImmunoSEQ® Technology Can Identify T-Cell Receptors Associated with Crohn’s Disease
Published: 2022-02-18 (Crawled : 17:00) - globenewswire.com
ADPT | $2.6 0.78% 0.39% 2M
|
Commercial Services
|
| O: -0.77%
H: 1.76%
C: -4.73%
immunoseq technology disease cel biotech iot t-cell
Gracell Biotechnologies Doses First Patients in First-in-Human Clinical Trial Evaluating GC012F, its Dual-Targeting FasTCAR-T Therapy, in B-Cell Non-Hodgkin's Lymphoma
Published: 2022-02-17 (Crawled : 14:00) - biospace.com/
GRCL | $10.25 -0.29% 6.4M
|
Manufacturing
|
| O: 0.53%
H: 2.65%
C: -5.82%
gc012 car-t trial cel therapy biotech iot t-cell
SQZ Biotechnologies Announces Publication of Comprehensive Preclinical Research on SQZ® APC’s Ability to Overcome Fundamental Biological Barrier to Effective and Efficient Killer T Cell Activation
Published: 2022-02-01 (Crawled : 12:30) - biospace.com/
SQZ | $0.435 0.0% 30M
|
Health Technology
|
| O: 19.91%
H: 0.0%
C: -1.85%
sqz research cel preclinical biotech iot t-cell pre-clinical
TCR² Therapeutics and Arbor Biotechnologies Establish Collaboration to Advance Allogeneic TRuC-T Cell Therapies
Published: 2022-01-04 (Crawled : 20:00) - biospace.com/
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
therapeutics cel collaboration biotech iot therapy t-cell
Sana Biotechnology Presentations at 2021 ASH Annual Meeting Highlight Progress with Platforms and CAR T Cell Programs
Published: 2021-12-12 (Crawled : 16:20) - globenewswire.com
SANA | $8.58 6.06% 5.71% 1.2M
|
| Email alert
Add to watchlist
technology presentation biotech iot platform t-cell
Atara Biotherapeutics Announces Preliminary Results for ATA2271, a Next-Generation Autologous Mesothelin-targeted CAR T-cell Therapy for Solid Tumors, at ESMO Immuno-Oncology Congress 2021
Published: 2021-12-09 (Crawled : 14:00) - biospace.com/
ATRA | $0.7147 -0.54% -1.2% 640K
|
Health Technology
|
| O: -2.59%
H: 1.04%
C: -5.89%
ata2271 solid tumors therapeutics therapy results iot t-cell
SQZ Biotechnologies Lead Cell Therapy Candidate Generated Monotherapy Clinical Response Correlated with Substantial CD8 T Cell Tumor Infiltration in HPV+ Solid Tumor at Highest Dose
Published: 2021-12-02 (Crawled : 12:30) - biospace.com/
SQZ | $0.435 0.0% 30M
|
Health Technology
|
| O: -10.45%
H: 5.31%
C: -5.72%
hpv therapy biotech iot t-cell
Gracell Biotechnologies Granted FDA Orphan Drug Designation for FasTCAR-enabled BCMA/CD19 Dual-targeting CAR-T Cell Therapy Candidate GC012F for the Treatment of Multiple Myeloma
Published: 2021-11-19 (Crawled : 12:00) - biospace.com/
GRCL | $10.25 -0.29% 6.4M
|
Manufacturing
|
| O: 21.78%
H: 4.25%
C: -19.25%
gc012 treatment fda orphan drug therapy car-t biotech drug iot granted t-cell designation
Gracell Biotechnologies to Present Preclinical Results of TruUCAR-enabled CD19/CD7 Dual-Directed Allogeneic CAR-T Cell Therapy (GC502) for B-Cell Malignancies at the 63rd ASH Annual Meeting
Published: 2021-11-04 (Crawled : 13:00) - prnewswire.com
GRCL | $10.25 -0.29% 6.4M
|
Manufacturing
| Email alert
Add to watchlist
therapy car-t results biotech iot preclinical t-cell pre-clinical
Worldwide CAR-T Cell Therapy Industry - Featuring Aleta BioTherapeutics, Atara Biotherapeutics and BioNTech Among Others
Published: 2021-06-04 (Crawled : 16:00) - prnewswire.com
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: 0.28%
H: 0.38%
C: -0.06%
SRNE | $0.02 33.33% -8.85% 97K
|
Health Technology
|
| O: 1.73%
H: 2.43%
C: -1.58%
PGEN | $1.42 1.43% 1.41% 570K
|
Health Technology
|
| O: 1.07%
H: 3.01%
C: 0.45%
PSTX | $2.07 -4.17% -4.6% 460K
|
Health Technology
|
| O: -1.07%
H: 2.53%
C: 0.84%
MBIO | $0.3501 -2.67% -2.77% 120K
|
Health Technology
|
| O: 2.46%
H: 8.41%
C: 6.91%
GILD | $67.08 0.08% 0.06% 6.2M
|
Health Technology
|
| O: 0.47%
H: 1.17%
C: 0.96%
FATE | News | $4.3 -5.29% -5.58% 1.7M
|
Health Technology
|
| O: 1.53%
H: 9.81%
C: 6.61%
BLCM | $0.0748 381.28% 6.1K
|
Health Technology
|
| O: 0.0%
H: 2.74%
C: 0.68%
ANIX | $3.18 3.58% 0.97% 350K
|
Health Technology
|
| O: 1.78%
H: 6.25%
C: 3.0%
therapy car-t iot t-cell
Sensei Biotherapeutics Announces New Clinical Data from the Ongoing Phase 1/2 Combination Trial of SNS-301 in Patients with Squamous Cell Carcinoma of the Head and Neck
Published: 2021-05-19 (Crawled : 22:00) - globenewswire.com
SNSE | $0.9917 -0.6% -3.93% 55K
|
|
| O: 0.82%
H: 35.47%
C: 29.05%
ongoing phase 1 iot trial phase 3 phase 2 cell carcinoma
Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection
Published: 2021-02-23 (Crawled : 13:01) - globenewswire.com
ADPT | $2.6 0.78% 0.39% 2M
|
Commercial Services
|
| O: -1.27%
H: 2.57%
C: 1.36%
covid test biotech iot t-cell injection infections
PDS Biotech and Farmacore Announce Blanver to Join Consortium to Commercialize Novel Versamune®-Based T-Cell Inducing COVID-19 Vaccine
Published: 2021-02-22 (Crawled : 14:01) - globenewswire.com
PDSB | $3.25 1.56% 1.84% 450K
|
Health Technology
|
| O: 1.19%
H: 21.33%
C: 6.85%
covid biotech vaccine iot t-cell commercialization
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.